Centro de Investigaciones Clínicas Viña Del Mar

Centro de Investigaciones Clínicas Viña Del Mar
Anabaena 336, Viña del Mar, Valparaíso
Select an option

Our team

Medical staff
Ilan Daniel Perrot Rosenberg

Open studies

Lung cancer
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations - TROPION-Lung08 - AstraZenecaSee more
A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer - Be6A Lung-01 - Seagen Inc.See more
A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer - MARYGOLD - AmgenSee more
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) - Eucalyptus - AmgenSee more
Multiple myeloma
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) - Successor-1 - Bristol-Myers SquibbSee more
Non-Hodgkin Lymphoma
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma - GOLSEEK-1 - CelgeneSee more
Urothelial cancer
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 - KEYNOTE-D74 - Seagen Inc.See more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy